Invention Grant
- Patent Title: Exendin-4 derivatives as dual GLP1/glucagon agonists
-
Application No.: US15837958Application Date: 2017-12-11
-
Publication No.: US10758592B2Publication Date: 2020-09-01
- Inventor: Torsten Haack , Michael Wagner , Bernd Henkel , Siegfried Stengelin , Andreas Evers , Martin Bossart
- Applicant: SANOFI
- Applicant Address: FR Paris
- Assignee: SANOFI
- Current Assignee: SANOFI
- Current Assignee Address: FR Paris
- Agency: Lathrop GPM LLP
- Agent James H. Velema, Esq.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@736e5351 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4a1f6508
- Main IPC: A61K38/26
- IPC: A61K38/26 ; C07K14/575 ; C07K14/605 ; A61K38/28 ; A61K45/06 ; A61K38/22 ; A61K38/00
Abstract:
The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.
Public/Granted literature
- US20180185450A1 EXENDIN-4 DERIVATIVES AS DUAL GLP1/GLUCAGON AGONISTS Public/Granted day:2018-07-05
Information query
IPC分类:
